West Pharmaceutical Services, Inc. (WST) Shareholders & Insider Trades

Executive TeamFinancialsSegmentsShareholders

West Pharmaceutical Services shareholders at a glance

The largest holder of West Pharmaceutical Services stock is Vanguard Capital Management LLC, with 4.6 million shares (6.55% of the company), worth about $1.57 billion as of September 25, 2026. The 10 largest holders together own 43.1%.

In Q2 2026, 861 institutional holdings reports listed shares worth $25.40 billion.

Insiders reported 48 transactions in the last two years: 3 sales worth $1.35 million and no purchases. The newest one on file is from May 12, 2026 (Campbell Shane Alden, Officer).

Major holders as of September 25, 2026; quarterly totals from institutional holdings reports (latest Q2 2026); insider transactions on file through May 12, 2026.

WST logo

West Pharmaceutical Services, Inc.

WSTUnited States
Healthcare

Shareholders Summary

2026Q2

Filings
861
Options Value
$114.00M
Value (excl. Options)
$25.40B
Shares (excl. Options)
-

Ownership by Type

Geographic Distribution

Largest West Pharmaceutical Services shareholders

HolderShares% of companyValue
Vanguard Capital Management LLC4.6 million6.55%$1.6B
BlackRock Advisors LLC4.5 million6.46%$1.6B
Vanguard Portfolio Management LLC4.0 million5.71%$1.4B
Fidelity Management & Research Co. LLC3.6 million5.08%$1.2B
State Street Corporation3.3 million4.76%$1.1B
Artisan Partners Holdings LP2.4 million3.43%$823.0M
BNY Mellon Investment Adviser, Inc.2.1 million2.96%$711.0M
Generation Investment Management LLP2.0 million2.88%$692.0M
Geode Capital Management LLC1.9 million2.70%$649.0M
T. Rowe Price Investment Management, Inc.1.8 million2.56%$616.0M

As of September 25, 2026.

West Pharmaceutical Services institutional holdings by quarter

QuarterReportsSharesValue
Q2 2026861–$25.4B
Q1 202677671.1 million$17.8B
Q4 202583570.6 million$19.3B
Q3 202579069.1 million$18.1B
Q2 202576270.9 million$15.5B
Q1 202574969.9 million$15.6B
Q4 202478369.9 million$22.9B
Q3 202477469.7 million$20.8B

Shares and value held by institutions that file quarterly holdings reports (options not included).

West Pharmaceutical Services insider trades

InsiderDateTitleTransactionValue
Campbell Shane AldenMay 12, 2026Officer--–
Lockhart Stephen HMay 4, 2026DirectorStock Award(Grant) at price 0.00 per share.–
Keller Deborah LMay 4, 2026DirectorStock Award(Grant) at price 0.00 per share.–
Joseph Molly E.May 4, 2026DirectorStock Award(Grant) at price 0.00 per share.–
Feehery William F.May 4, 2026DirectorStock Award(Grant) at price 0.00 per share.–
Michels Douglas AMay 4, 2026DirectorStock Award(Grant) at price 0.00 per share.–
Pucci PaoloMay 4, 2026DirectorStock Award(Grant) at price 0.00 per share.–
Buthman Mark AMay 4, 2026DirectorStock Award(Grant) at price 0.00 per share.–
Friel Robert FMay 4, 2026DirectorStock Award(Grant) at price 0.00 per share.–
Haugen Janet BrutscheaMay 4, 2026DirectorStock Award(Grant) at price 0.00 per share.–
Lai-Goldman Myla PMay 4, 2026DirectorStock Award(Grant) at price 0.00 per share.–
Winters ChadApr 27, 2026OfficerSale at price 300.67 per share.$269,399

Newest 12 of 48 insider transactions in the last two years.

Questions and answers

Who owns the most West Pharmaceutical Services stock?

Vanguard Capital Management LLC, with 6.55% of the company (as of September 25, 2026). Next: BlackRock Advisors LLC (6.46%) and Vanguard Portfolio Management LLC (5.71%).

How many institutions own West Pharmaceutical Services stock?

861 institutional holdings reports listed West Pharmaceutical Services shares in Q2 2026 worth $25.40 billion.

Are West Pharmaceutical Services insiders buying or selling the stock?

In the last two years insiders reported 3 sales and no purchases (48 transactions in all); the newest on file is from May 12, 2026.

Disclaimer: This analysis is for informational and educational purposes only and does not constitute financial, investment, tax, or legal advice. Data may be incomplete, delayed, or contain inaccuracies. Consult with a qualified financial advisor before making any investment decisions.
LinkedInLinkedInXXYouTubeYouTube